aixbiotech.ch https://validator.w3.org/feed/docs/rss2.html AI vendor due diligence for biotech executives: what to ask before you buy AI clinical trial site selection: how to find the right sites before your competitor does AI in biotech deal structuring: how to model partnerships before you sign them AI in aggregate safety reporting: how to cut PBRER production time without cutting corners AI post-approval regulatory monitoring: how to stay ahead of lifecycle obligations AI payer intelligence in biotech: how to stop guessing what reimbursement bodies want AI distributor performance monitoring in emerging markets: beyond the quarterly review AI in CDMO selection and management: how to pick the right partner and hold them accountable AI in biotech talent acquisition: how to hire faster without lowering the bar Neurocrine acquires Soleno for $2.9B: what a $2.9B rare disease bet signals about the 2026 M&A wave AI in pharmaceutical manufacturing quality: from reactive QC to predictive control Anthropic acquires Coefficient Bio for $400M: what it means for AI drug discovery AI cold chain optimisation for biologics: how to stop losing product to temperature excursions AI key account management in biotech: from relationship tracking to revenue intelligence AI Signal Detection in Pharmacovigilance: Find the Safety Signal First Home AI pricing strategy in APAC and Middle East biotech markets: beyond the EU5 reference price 26 October 2025 — Flagship bets on AI biotech + the prompt that rewrites your lab SOPs Lilly’s Foundayo FDA Approval Resets the GLP-1 Commercial Playbook FDA Converts Tecartus to Full Approval in Relapsed Mantle Cell Lymphoma $12 Billion in One Day: What Biogen and Lilly Deals Signal AI Is Compressing Every Layer of Biotech at the Same Time AI Biotech Valuation Modeling: Why the rNPV Spreadsheet Is No Longer Enough AI Regulatory Submission Drafting: From Months to Weeks Without Cutting Corners AI Price Corridor Modeling: Stop Leaving Money on the Table at Launch AI Is Not Just a Work Tool. It Is a Personal Competitive Weapon. Latest Posts AI Patient Recruitment Optimization: Fix the Problem That Kills Half Your Timeline One Injection Restored Hearing in Every Patient. What Gene Therapy Just Changed. AI for Pharma Office Workers: The Compliant Path Forward AI Territory Optimization for Biotech Sales Teams: From Static Maps to Dynamic Intelligence 12 October 2025 – AstraZeneca inks $555M deal with AI-powered gene therapy startup Algen 04 January 2026 – Big Pharma doubles down on AI discovery + the prompt that cleans up messy SOPs AI in Specialty Drug Demand Forecasting: From Missed Targets to Measurable Results 19 October 2025 – Takeda doubles down on AI + the slide prompt that saves your Monday About Biotech legal teams: Harvey’s acquisition is a real signal Swiss Biotech directory and AI Maturity audit How AI Closes the $356 Billion Distributor Margin Gap in Biotech Unitree stages G1 humanoid robot boxing match at CES Stomata In-Sight watches leaf pores breathe in real time Privacy Policy How AI Is Cutting Supply Chain Costs Across Biotech AI Launch Strategy in Emerging Markets: Beyond the EU5 Playbook Feedback Welcome to AIxBiotech Newsletter | #1 AI & Biotech Newsletter How AI Is Cutting Supply Chain Costs Across Biotech The New Biotech Skill: AI Fluency at the Office “Dead as a dodo” might soon need a rewrite The 2025 Drug Sales Ranking Is a Commercial Disruption Map